Becton Dickinson and
No price chart data available for 1D timeframe.
Rating
Why Price Moved
Shares are trading higher after strong AGILITY tri...
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes es...
Latest News
3 days ago · zacks.com
Becton Dickinson (BDX) Earnings Expected to Grow: Should You Buy?Becton Dickinson (BDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 days ago · prnewswire.com
BD Advances Portal Hypertension Care in the U.S. with Support for More Personalized Treatment OptionsThe launch of the Liverty™ TIPS Stent Graft gives physicians flexibility to tailor treatment for patients. FRANKLIN LAKES, N.J.
6 days ago · seekingalpha.com
First Eagle U.S. Value Fund Q3 2026 Portfolio ReviewU.S. Fund A Shares (without sales charge) posted a return of 4.36% in third-quarter 2026. The US Fund outperformed the S&P 500 Index in the period. Shares of Meta performed well following the strong reception of Muse, its personalized AI assistance app.
11 days ago · zacks.com
BDX Stock Gains 25.5% in Six Months: What's Behind the Rally?BD's 25.5% rally reflects stronger execution, portfolio reshaping, product innovation and U.S. manufacturing investments despite tariffs and cost pressures.
18 days ago · zacks.com
BD's Revello Stent Shows Strong AGILITY Trial Results for PAD PatientsBDX's Revello stent shows strong nine-month AGILITY trial results, with high vessel patency and low failure rates, boosting its peripheral vascular prospects.
24 days ago · zacks.com
Will Becton Dickinson (BDX) Beat Estimates Again in Its Next Earnings Report?Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
25 days ago · prnewswire.com
BD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2026FRANKLIN LAKES, N.J., Oct. 8, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m.
26 days ago · zacks.com
BDX Expands U.S. Manufacturing With $19B Healthcare InvestmentBD plans a $19B U.S. investment, including $3B for manufacturing, to boost domestic medical consumables capacity and supply-chain resilience.
26 days ago · prnewswire.com
BD Strengthens Leadership in Peripheral Vascular Innovation with Positive AGILITY Trial ResultsData through 9 months of follow-up from this ongoing 36-month study demonstrate high vessel patency, low reintervention rates and meaningful improvements in mobility and symptoms, providing evidence supporting the treatment of complex iliac artery disease. FRANKLIN LAKES, N.J.
27 days ago · benzinga.com
Becton Dickinson Commits Massive $19 Billion To Expand Domestic Medical ManufacturingBecton, Dickinson and Company (NYSE:BDX), a global medical technology firm and the largest domestic producer of critical medical consumables, on Tuesday announced a monumental partnership with the U.S. government.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove BDX